Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01084928 · ClinicalTrials.gov registry record · NA

A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT01084928: Completed NA study, sponsored by Emory University.

NCT01084928 is a NA study that has completed, run by Emory University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01084928, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The South Asian Community, people with origins in India, Pakistan, Bangladesh, Maldives, Nepal, Sri Lanka, or Bhutan, are more likely to get diabetes, get diabetes at younger ages, and do worse health-wise once they have diabetes than the general population. This study will test the feasibility and community acceptability of a culturally appropriate lifestyle intervention for the prevention of diabetes in the South Asian community. The outcomes of this project could be used to plan larger interventions to prevent diabetes in South Asians, a rapidly growing segment of the US population.

Interventions

  • BEHAVIORAL Lifestyle Intervention Classes

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2010-04
Est. Completion 2012-07
Phase NA
Emory University

1,208 total trials

What the finished NCT01084928 record still lists

NCT01084928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Lifestyle Intervention Classes is the first listed.

NCT01084928 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01084928 about?

NCT01084928 is a clinical study titled "A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians". The South Asian Community, people with origins in India, Pakistan, Bangladesh, Maldives, Nepal, Sri Lanka, or Bhutan, are more likely to get diabetes, get diabetes at younger ages, and do worse health-wise once they have diabetes than the general population. This study will test the feasibility and ...

What is the current status of trial NCT01084928?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2010-04. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01084928?

The interventions under investigation include: Lifestyle Intervention Classes (BEHAVIORAL).

Who is sponsoring clinical trial NCT01084928?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01084928's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01084928, the US trial registry maintained by the National Library of Medicine. NCT01084928 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.